Navigation Links
PharmAthene Reports First Quarter 2009 Financial and Operational Results
Date:5/15/2009

a novel bioscavenger for the prevention and treatment of morbidity and mortality associated with exposure to chemical nerve agents
  • RypVax(TM) - a recombinant dual antigen vaccine for plague

  • For more information about PharmAthene, please visit www.PharmAthene.com.

    Statement on Cautionary Factors

    Except for the historical information presented herein, matters discussed may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Statements that are not historical facts, including statements preceded by, followed by, or that include the words "potential"; "believe"; "anticipate"; "intend"; "plan"; "expect"; "estimate"; "could"; "may"; "should"; or similar statements are forward-looking statements. PharmAthene disclaims, however, any intent or obligation to update these forward-looking statements. Risks and uncertainties include risk associated with the reliability of the results of the studies relating to human safety and possible adverse effects resulting from the administration of the Company's product candidates, unexpected funding delays and/or reductions or elimination of U.S. government funding for one or more of the Company's development programs, including without limitation our bid related to SparVax(TM) under the DHHS Request for Proposals for an Anthrax Recombinant Protective Antigen (rPA) Vaccine for the Strategic National Stockpile, the award of government contracts to our competitors, unforeseen safety issues, challenges related to the development, scale-up, technology transfer, and/or process validation of manufacturing processes for our product cand
    '/>"/>

    SOURCE PharmAthene, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related biology technology :

    1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
    2. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
    3. PharmAthene Named as Contractor in $13.9 Million Award Notice Published by the Department of Health and Human Services
    4. Delaware Court Denies Motion by SIGA Technologies Seeking to Dismiss PharmAthenes Legal Action in Breach of Contract Lawsuit Against SIGA
    5. PharmAthene to Present at the BIO CEO & Investor Conference 2008
    6. PharmAthene Enhances Executive Leadership Team and Appoints Joan Fusco, Ph.D. Senior Vice President of Operations
    7. PharmAthene Completes Pharmacokinetic Studies of Protexia(R); Program on Target for IND Filing in 2008
    8. PharmAthene to Present at the Cowen and Company 28th Annual Health Care Conference
    9. PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia
    10. PharmAthene to Delay Release of Full Year 2007 Financial Results
    11. PharmAthene Year-End 2007 Earnings Conference Call and Webcast Scheduled for Monday, March 31, 2008
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/1/2014)... , Cambridge Semantics, the leading provider of Smart ... announced its participation in the 2014 Big Data Leaders ... provide semantic linkage and meaning to Big Data to ... diverse data. Ben Szekely, vice president and founding engineer ... sciences data lake” and an approach for collecting and ...
    (Date:10/1/2014)... BETHESDA, Md. , Oct. 1, 2014 /PRNewswire/ ... committed to the fostering and monetization of intellectual ... Spherix,s litigation against VTech and Uniden in the ... Texas has been rescheduled ... scheduled for October 2, 2014.  The Court Order ...
    (Date:10/1/2014)... Irvine, CA (PRWEB) September 30, 2014 ... for user-friendly, cost-effective tools to address sales, training ... PMG has developed innovative mobile applications to ... studies, outlining the agency’s latest customized mobile app ... http://www.studiopmg.com/work . , In partnership with Toyota, ...
    (Date:10/1/2014)... (PRWEB) October 01, 2014 The U.S. ... to Southern Illinois University Edwardsville as part of the ... initiative. The funding is co-administered by the Department of ... Biden, Secretary of Labor Thomas E. Perez and Secretary ... million in job-driven training grants to nearly 270 colleges ...
    Breaking Biology Technology:Cambridge Semantics to Present ‘A Useful Approach to Big Data’ at 2014 Big Data Leaders Forum 2Markman Hearing Date for VTech and Uniden Litigation Now Set for November 10, 2014 2Digital Agency Studio PMG Launches New Case Studies on Website 2U.S. Dept. of Labor Awards SIUE Nearly $10-Million Grant 2U.S. Dept. of Labor Awards SIUE Nearly $10-Million Grant 3U.S. Dept. of Labor Awards SIUE Nearly $10-Million Grant 4
    ... Esker Software, worldwide leader in ... Esker Fax and VSI-FAX(R) product ... Notes 3.0. This new solution ... communicate more efficiently, effectively, and ...
    ... often encounter certain genes, chromosomal regions or entire ... CloneSmart technology was designed specifically to eliminate many ... individual gene or a complete genome. The technology ... clone sequences that are difficult to clone with ...
    ... Information Networks Corporation, a leading Midwest provider of data ... it has been selected by Microsoft as a featured ... Studio .NET 2003 Launch. , , ,Scheduled for ... inMilwaukee, Wisconsin, Berbee will speak in depth about addressing ...
    Cached Biology Technology:Molecular Cloning Systems Gets Distributor 2
    (Date:9/30/2014)... Evidence of the environmental effects of moorland burning is ... the subject, with the aim of relieving tensions on ... , The EMBER (Effects of Moorland Burning on the ... burning on moorland, which is practised predominantly to support ... impacts on peat hydrology, peat chemistry and physical properties, ...
    (Date:9/30/2014)... monkeys have captured the popular attention of both children ... cycle -- sold as dehydrated eggs, these tiny brine ... than a tank of salt water. , Physicists, ... zooplankton, brine shrimp vertically migrate in large groups in ... surface at night and retreating deeper during the day. ...
    (Date:9/30/2014)... Medicine reports positive results of a phase 1 ... of lung cancer marked by rearrangement of the gene ... advanced non-small cell lung cancer testing positive for ROS1 ... 3 complete responses and 33 partial responses. Median progression-free ... to resume its growth after being slowed by treatment ...
    Breaking Biology News(10 mins):Grouse moor burning causes widespread environmental changes 2Laser-guided sea monkeys show how zooplankton migrations may affect global ocean currents 2NEJM: Crizotinib effective in Phase 1 trial against ROS1 lung cancer 2
    ... at the Smithsonian Institution and the Hawaii Institute of ... have created the first frozen bank for Hawaiian corals ... to preserve their diversity in Hawaii. Mary Hagedorn, an ... with the Smithsonian Conservation Biology Institute, leads the laboratory ...
    ... treatment, also brings debilitating side effects such as nausea, liver ... a new way to deliver this life-saving therapy to cancer ... has been invented by Dr. Dan Peer of Tel ... Center for Nano Science and Nano Technology together with Prof. ...
    ... More than 120 sturgeon and paddlefish scientists and enthusiasts from ... 2 in Bozeman and at Chico Hot Springs in Montana. ... North American Chapter of the World Sturgeon Conservation Society and ... in North America. The meeting will begin in Bozeman, ...
    Cached Biology News:Smithsonian scientists help create first frozen repository for Hawaiian coral 2A cluster bomb for cancer care 2
    Homo sapiens MEP50 protein, mRNA...
    Mouse H60 Allophycocyanin MAb (Clone 205326) ENTREZ GeneID: 15101...
    RAB32, member RAS oncogene family, mRNA (cDNA clone MGC:13500 IMAGE:4280407), complete cds...
    EDTA, 0.5 M solution, 100 ml. Ethylene diaminetetraacetic acid.Sterile, nuclease-free. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
    Biology Products: